| Quarter | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 992 | 1,033 | 1,319 | 1,159 | 1,360 | 1,241 | 1,565 | 1,769 | 1,538 | 1,550 | 2,116 | 2,274 | |
Growth YoY Revenue Growth YoY% | 33.8 | 30.0 | 36.1 | 37.1 | 20.1 | 18.6 | 52.6 | 13.1 | 24.9 | 35.2 | 28.6 | |
Expenses ExpensesCr | 969 | 1,021 | 1,152 | 1,136 | 1,301 | 1,237 | 1,470 | 1,761 | 1,600 | 1,685 | 2,005 | 2,173 |
| 23 | 12 | 167 | 23 | 58 | 3 | 95 | 8 | -62 | -136 | 111 | 101 | |
OPM OPM% | 2.3 | 1.1 | 12.6 | 2.0 | 4.3 | 0.3 | 6.1 | 0.4 | -4.0 | -8.8 | 5.3 | 4.4 |
| 189 | 230 | 304 | 277 | 320 | 315 | 357 | 587 | 334 | 386 | 725 | 661 | |
Interest Expense Interest ExpenseCr | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
PBT PBTCr | -8 | 5 | 157 | -19 | 13 | 13 | 206 | 98 | -35 | -88 | 181 | 184 |
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 26 | 0 | 0 | 21 | 46 | |
| -8 | 5 | 157 | -19 | 13 | 13 | 206 | 71 | -35 | -88 | 159 | 138 | |
Growth YoY PAT Growth YoY% | -403.6 | 302.2 | 73.9 | 271.5 | 189.1 | 31.2 | 479.6 | -370.9 | -761.9 | -22.7 | 92.9 | |
NPM NPM% | -0.8 | 0.4 | 11.9 | -1.6 | 1.0 | 1.1 | 13.2 | 4.0 | -2.3 | -5.7 | 7.5 | 6.1 |
| 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.1 | 1.1 | 0.4 | -0.2 | -0.5 | 0.9 | 0.8 |
| Quarter | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 992 | 1,033 | 1,319 | 1,159 | 1,360 | 1,241 | 1,565 | 1,769 | 1,538 | 1,550 | 2,116 | 2,274 | |
Growth YoY Revenue Growth YoY% | 33.8 | 30.0 | 36.1 | 37.1 | 20.1 | 18.6 | 52.6 | 13.1 | 24.9 | 35.2 | 28.6 | |
Expenses ExpensesCr | 969 | 1,021 | 1,152 | 1,136 | 1,301 | 1,237 | 1,470 | 1,761 | 1,600 | 1,685 | 2,005 | 2,173 |
| 23 | 12 | 167 | 23 | 58 | 3 | 95 | 8 | -62 | -136 | 111 | 101 | |
OPM OPM% | 2.3 | 1.1 | 12.6 | 2.0 | 4.3 | 0.3 | 6.1 | 0.4 | -4.0 | -8.8 | 5.3 | 4.4 |
| 189 | 230 | 304 | 277 | 320 | 315 | 357 | 587 | 334 | 386 | 725 | 661 | |
Interest Expense Interest ExpenseCr | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
PBT PBTCr | -8 | 5 | 157 | -19 | 13 | 13 | 206 | 98 | -35 | -88 | 181 | 184 |
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 26 | 0 | 0 | 21 | 46 | |
| -8 | 5 | 157 | -19 | 13 | 13 | 206 | 71 | -35 | -88 | 159 | 138 | |
Growth YoY PAT Growth YoY% | -403.6 | 302.2 | 73.9 | 271.5 | 189.1 | 31.2 | 479.6 | -370.9 | -761.9 | -22.7 | 92.9 | |
NPM NPM% | -0.8 | 0.4 | 11.9 | -1.6 | 1.0 | 1.1 | 13.2 | 4.0 | -2.3 | -5.7 | 7.5 | 6.1 |
| 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.1 | 1.1 | 0.4 | -0.2 | -0.5 | 0.9 | 0.8 |
| Financial Year | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|
Revenue RevenueCr | 2,112 | 3,161 | 4,196 | 5,324 | 6,474 | 7,478 |
Growth Revenue Growth% | 49.7 | 32.7 | 26.9 | 21.6 | 26.0 | |
Expenses ExpensesCr | 2,923 | 3,991 | 5,015 | 6,227 | 7,708 | 7,463 |
| -811 | -829 | -819 | -903 | -1,235 | 15 | |
OPM OPM% | -38.4 | -26.2 | -19.5 | -17.0 | -19.1 | 0.2 |
| 0 | 364 | 218 | 142 | 1 | 2,105 | |
Interest Expense Interest ExpenseCr | 0 | 0 | 0 | 0 | 0 | 0 |
PBT PBTCr | -197 | 13 | 82 | 214 | 127 | 242 |
| 0 | 0 | 0 | 0 | -4 | 67 | |
PAT PATCr | -197 | 13 | 82 | 214 | 131 | 174 |
Growth PAT Growth% | 106.4 | 552.7 | 160.9 | -38.8 | -42.6 | |
NPM NPM% | -9.3 | 0.4 | 1.9 | 4.0 | 2.0 | 2.3 |
| -1.4 | 0.1 | 0.5 | 1.2 | 2.0 | 0.9 |
| Financial Year | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|
Revenue RevenueCr | 2,112 | 3,161 | 4,196 | 5,324 | 6,474 | 7,478 |
Growth Revenue Growth% | 49.7 | 32.7 | 26.9 | 21.6 | 26.0 | |
Expenses ExpensesCr | 2,923 | 3,991 | 5,015 | 6,227 | 7,708 | 7,463 |
| -811 | -829 | -819 | -903 | -1,235 | 15 | |
OPM OPM% | -38.4 | -26.2 | -19.5 | -17.0 | -19.1 | 0.2 |
| 0 | 364 | 218 | 142 | 1 | 2,105 | |
Interest Expense Interest ExpenseCr | 0 | 0 | 0 | 0 | 0 | 0 |
PBT PBTCr | -197 | 13 | 82 | 214 | 127 | 242 |
| 0 | 0 | 0 | 0 | -4 | 67 | |
PAT PATCr | -197 | 13 | 82 | 214 | 131 | 174 |
Growth PAT Growth% | 106.4 | 552.7 | 160.9 | -38.8 | -42.6 | |
NPM NPM% | -9.3 | 0.4 | 1.9 | 4.0 | 2.0 | 2.3 |
| -1.4 | 0.1 | 0.5 | 1.2 | 2.0 | 0.9 |
| Financial Year | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|
Equity Capital Equity CapitalCr | 1,409 | 1,511 | 1,700 | 1,827 | 1,847 | 0 |
Reserves ReservesCr | -903 | -683 | 1,283 | 1,949 | 1,939 | 0 |
Borrowings BorrowingsCr | 250 | 250 | 250 | 250 | 250 | 0 |
Other Liabilities Other LiabilitiesCr | 0 | 0 | -932 | -718 | -584 | 0 |
Total Liabilities Total LiabilitiesCr | 756 | 1,078 | 2,301 | 3,308 | 3,452 | 0 |
| 59 | 75 | 88 | 0 | |||
Advances AdvancesCr | 229 | 353 | 532 | 1,289 | 1,325 | |
Cash Equivalents Cash EquivalentsCr | 59 | 102 | 143 | 220 | 159 | 0 |
Other Assets Other AssetsCr | 468 | 623 | 1,567 | 1,723 | 1,880 | 0 |
Total Assets Total AssetsCr | 756 | 1,078 | 2,301 | 3,308 | 3,452 | 0 |
| Financial Year | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|
Equity Capital Equity CapitalCr | 1,409 | 1,511 | 1,700 | 1,827 | 1,847 | 0 |
Reserves ReservesCr | -903 | -683 | 1,283 | 1,949 | 1,939 | 0 |
Borrowings BorrowingsCr | 250 | 250 | 250 | 250 | 250 | 0 |
Other Liabilities Other LiabilitiesCr | 0 | 0 | -932 | -718 | -584 | 0 |
Total Liabilities Total LiabilitiesCr | 756 | 1,078 | 2,301 | 3,308 | 3,452 | 0 |
| 59 | 75 | 88 | 0 | |||
Advances AdvancesCr | 229 | 353 | 532 | 1,289 | 1,325 | |
Cash Equivalents Cash EquivalentsCr | 59 | 102 | 143 | 220 | 159 | 0 |
Other Assets Other AssetsCr | 468 | 623 | 1,567 | 1,723 | 1,880 | 0 |
Total Assets Total AssetsCr | 756 | 1,078 | 2,301 | 3,308 | 3,452 | 0 |
| Financial Year | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| 338 | 593 | 813 | 1,654 | 905 | |
| -723 | -829 | -1,882 | -2,348 | -961 | |
| 374 | 280 | 1,110 | 771 | -5 | |
Net Cash Flow Net Cash FlowCr | -12 | 43 | 41 | 78 | -62 |
Free Cash Flow Free Cash FlowCr | 309 | 555 | 780 | 1,614 | 857 |
CFO To PAT CFO To PAT% | -171.9 | 4,724.6 | 992.9 | 774.8 | 691.9 |
CFO To EBITDA CFO To EBITDA% | -41.6 | -71.5 | -99.2 | -183.2 | -73.3 |
| Financial Year | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| 338 | 593 | 813 | 1,654 | 905 | |
| -723 | -829 | -1,882 | -2,348 | -961 | |
| 374 | 280 | 1,110 | 771 | -5 | |
Net Cash Flow Net Cash FlowCr | -12 | 43 | 41 | 78 | -62 |
Free Cash Flow Free Cash FlowCr | 309 | 555 | 780 | 1,614 | 857 |
CFO To PAT CFO To PAT% | -171.9 | 4,724.6 | 992.9 | 774.8 | 691.9 |
CFO To EBITDA CFO To EBITDA% | -41.6 | -71.5 | -99.2 | -183.2 | -73.3 |
| Financial Year | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | Current |
|---|---|---|---|---|---|---|
Market Cap Market CapitalizationCr | 14,253 | 12,954 | 14,794 | |||
Price To Earnings Price To Earnings | 66.7 | 98.8 | 84.2 | |||
Price To Sales Price To Sales | 2.6 | 1.9 | 2.0 | |||
Price To Book Price To Book | 3.8 | 3.4 | 3.9 | |||
EV To EBITDA EV To EBITDA | -15.8 | -10.6 | 1,023.5 | |||
OPM OPM% | -38.4 | -26.2 | -19.5 | -17.0 | -19.1 | 0.2 |
NPM NPM% | -9.3 | 0.4 | 1.9 | 4.0 | 2.0 | 2.3 |
ROCE ROCE% | -26.0 | 1.2 | 2.5 | 5.3 | 3.1 | |
ROE ROE% | -38.9 | 1.5 | 2.7 | 5.7 | 3.5 | |
ROA ROA% | -26.0 | 1.2 | 3.6 | 6.5 | 3.8 | |
| Financial Year | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | Current |
|---|---|---|---|---|---|---|
Market Cap Market CapitalizationCr | 14,253 | 12,954 | 14,794 | |||
Price To Earnings Price To Earnings | 66.7 | 98.8 | 84.2 | |||
Price To Sales Price To Sales | 2.6 | 1.9 | 2.0 | |||
Price To Book Price To Book | 3.8 | 3.4 | 3.9 | |||
EV To EBITDA EV To EBITDA | -15.8 | -10.6 | 1,023.5 | |||
OPM OPM% | -38.4 | -26.2 | -19.5 | -17.0 | -19.1 | 0.2 |
NPM NPM% | -9.3 | 0.4 | 1.9 | 4.0 | 2.0 | 2.3 |
ROCE ROCE% | -26.0 | 1.2 | 2.5 | 5.3 | 3.1 | |
ROE ROE% | -38.9 | 1.5 | 2.7 | 5.7 | 3.5 | |
ROA ROA% | -26.0 | 1.2 | 3.6 | 6.5 | 3.8 | |
Documents — Niva Bupa Health Insurance Company Ltd
Concall Transcript Summaries — Niva Bupa Health Insurance Company Ltd